April 2020: an ambulance picks up a possible covid patient near Liège. Whether the pill really makes a difference – and thus reduces the risk of hospitalization – will be known in September or October. — © afp
The drug company Merck is investigating whether molnupiravir can prevent the first symptoms from derailing into severe covid-19. It is one of the few drugs in the pipeline to avoid hospital admissions.
Read Also
- Covid, Gimbe: “Lockdown risk with 3.5 million over 50 unvaccinated” Aug 31, 2021
- Covid, at what point is the production of an all-Italian vaccine? Jul 13, 2021
- Seven good reasons to drink milk Jun 2, 2020
- Called a fruit that you cannot eat for Breakfast Jul 2, 2020
- The passwords of 25 thousand registered to take the medical residency exam were leaked Aug 21, 2021
- Champions League: Chelsea dominates the star draw of the season May 31, 2021
- The Codacons asks for Burioni to be expelled from the order of the Medici Jul 25, 2021
Maxie Eckert
Today at 11:34 AM
.
